Marinus Pharmaceuticals Approves Senior Management Retention and Change in Control Severance PlansOn December 17, 2024, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) announced the approval of a retention plan for senior management and an amendment to t
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Marinus Pharmaceuticals’s 8K filing here. About Marinus Pharmaceuticals (Get Free Report) Marinus Pharmaceuticals, Inc, a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies […]
26 Dec 02:04 · The Cerbat Gem